Definitive Healthcare (NASDAQ:DH) Posts Earnings Results, Beats Estimates By $0.01 EPS

Definitive Healthcare (NASDAQ:DH) released its earnings results on Thursday. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.01, FiscalAI reports. The company had revenue of $60.05 million during the quarter, compared to analyst estimates of $59.51 million. Definitive Healthcare had a negative net margin of 77.88% and a positive return on equity of 3.14%. Definitive Healthcare updated its FY 2025 guidance to 0.230-0.240 EPS and its Q4 2025 guidance to 0.050-0.060 EPS.

Definitive Healthcare Price Performance

Shares of DH stock traded up $0.28 during trading hours on Friday, hitting $2.93. The stock had a trading volume of 502,544 shares, compared to its average volume of 251,544. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.65 and a quick ratio of 1.65. The stock has a market capitalization of $419.40 million, a price-to-earnings ratio of 41.86 and a beta of 1.61. Definitive Healthcare has a one year low of $2.15 and a one year high of $5.68. The stock’s 50-day moving average price is $3.46 and its two-hundred day moving average price is $3.58.

Institutional Trading of Definitive Healthcare

A number of large investors have recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. boosted its position in shares of Definitive Healthcare by 564.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company’s stock valued at $25,191,000 after acquiring an additional 7,404,363 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new position in Definitive Healthcare during the second quarter valued at $4,247,000. Bank of America Corp DE grew its stake in shares of Definitive Healthcare by 23.7% in the 2nd quarter. Bank of America Corp DE now owns 769,397 shares of the company’s stock worth $3,001,000 after buying an additional 147,599 shares in the last quarter. AQR Capital Management LLC increased its holdings in shares of Definitive Healthcare by 56.7% in the 1st quarter. AQR Capital Management LLC now owns 590,149 shares of the company’s stock worth $1,706,000 after buying an additional 213,562 shares during the last quarter. Finally, Jane Street Group LLC raised its position in shares of Definitive Healthcare by 212.4% during the 2nd quarter. Jane Street Group LLC now owns 328,410 shares of the company’s stock valued at $1,281,000 after buying an additional 223,296 shares in the last quarter. Institutional investors own 98.67% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on DH. Stifel Nicolaus raised their price objective on shares of Definitive Healthcare from $5.00 to $6.00 and gave the company a “buy” rating in a research report on Friday, August 8th. Robert W. Baird set a $4.00 price target on Definitive Healthcare in a report on Friday, August 8th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Definitive Healthcare in a research note on Wednesday, October 8th. Finally, William Blair upgraded Definitive Healthcare to a “strong-buy” rating in a research report on Thursday. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $4.28.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.